Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

63 filings reported holding INZY - Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share as of Q4 2020.
Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18.4M shares of 64.5M outstanding shares and own 28.46% of the company stock.
Largest 10 shareholders include Novo Holdings A/S (2.57M shares), NEA Management Company, LLC (2.44M shares), Sofinnova Investments, Inc. (2.03M shares), RA CAPITAL MANAGEMENT, L.P. (2M shares), Pivotal bioVenture Partners Investment Advisor LLC (1.59M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.15M shares), CHI Advisors LLC (995K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (897K shares), Rock Springs Capital Management LP (831K shares), and BlackRock Inc. (631K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.